Success Metrics

Clinical Success Rate
96.0%

Based on 24 completed trials

Completion Rate
96%(24/25)
Active Trials
2(6%)
Results Posted
25%(6 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_4
8
24%
Ph phase_1
1
3%
Ph not_applicable
14
42%
Ph phase_3
4
12%
Ph phase_2
2
6%

Phase Distribution

1

Early Stage

2

Mid Stage

12

Late Stage

Phase Distribution29 total trials
Phase 1Safety & dosage
1(3.4%)
Phase 2Efficacy & side effects
2(6.9%)
Phase 3Large-scale testing
4(13.8%)
Phase 4Post-market surveillance
8(27.6%)
N/ANon-phased studies
14(48.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

24 of 27 finished

Non-Completion Rate

11.1%

3 ended early

Currently Active

2

trials recruiting

Total Trials

33

all time

Status Distribution
Active(3)
Completed(24)
Terminated(3)
Other(3)

Detailed Status

Completed24
unknown3
Withdrawn2
Recruiting2
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
33
Active
2
Success Rate
96.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (3.4%)
Phase 22 (6.9%)
Phase 34 (13.8%)
Phase 48 (27.6%)
N/A14 (48.3%)

Trials by Status

terminated13%
unknown39%
withdrawn26%
recruiting26%
completed2473%
not_yet_recruiting13%

Recent Activity

Clinical Trials (33)

Showing 20 of 33 trialsScroll for more
NCT03944733Not Applicable

Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions

Withdrawn
NCT06491394Phase 4

Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats

Completed
NCT05869422Not Applicable

Low-dose Iron Supplementation in Non-anaemic Iron-deficient Women

Completed
NCT06637137

Patient Blood Management in Patients Scheduled for Cardiac Surgery

Recruiting
NCT03036462Phase 4

Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality

Completed
NCT06670963Phase 4

Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial

Recruiting
NCT02278341Phase 3

Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis

Completed
NCT06570837

Iron Deficincy Among Children With type1 DM in Assiut University Hospital

Not Yet Recruiting
NCT05467423Not Applicable

Effect of Low-dose Versus Standard-dose Iron Supplementation on the Gut Microbiome

Completed
NCT05673161

Retrospective Evaluation of the Effect of Iron (Fe) Infusion on Complications in Anemic Patients Undergoing Thoracotomy

Completed
NCT04101461Not Applicable

The Oral Iron on the Prevention of Iron Deficiency Anemia in Obese Pregnant

Completed
NCT00284700Not Applicable

Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?

Completed
NCT02564796Phase 2

Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial

Terminated
NCT04975074Phase 4

Iron Deficiency Anemia in Twin Pregnancies

Unknown
NCT00684697Not Applicable

Iron Status and Myelination in Premature Infants

Completed
NCT02957643Phase 1

Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement

Completed
NCT00558454Phase 4

Iron Supplementation of Marginally Low Birth Weight Infants

Completed
NCT02829320Phase 3

Efficacy and Safety Study of GSK1278863 in Japanese Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Taking Erythropoiesis Stimulating Agents

Completed
NCT02233322Not Applicable

Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.

Completed
NCT02481375Not Applicable

Is Iron Deficiency the Cause of Anemia Among Women in Cambodia?

Completed

Drug Details

Intervention Type
DRUG
Total Trials
33